The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hudrisier, D.
Right arrow Articles by Joly, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hudrisier, D.
Right arrow Articles by Joly, E.
The Journal of Immunology, 2001, 166: 3645-3649.
Copyright © 2001 by The American Association of Immunologists

CUTTING EDGE

Cutting Edge: CTLs Rapidly Capture Membrane Fragments from Target Cells in a TCR Signaling-Dependent Manner1

Denis Hudrisier2,*, Joelle Riond{dagger}, Honoré Mazarguil{dagger}, Jean Edouard Gairin3,{dagger} and Etienne Joly3,{ddagger}

* Institut National de la Santé et de la Recherche Médicale, Unité 395, Centre Hospitalier Universitaire Purpan, BP3028; {dagger} Centre National de la Recherche Scientifique, Unité Mixte de Recherche 5089; and {ddagger} Centre National de la Recherche Scientifique, Unité Propre de Recherche 2163, Centre Hospitalier Universitaire Purpan, BP3028, Toulouse, France


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results and Discussion
 References
 
Upon encounter of a CTL with a target cell carrying foreign Ags, the TCR internalizes with its ligand, the peptide-MHC class I complex. However, it is unclear how this can happen mechanistically because MHC molecules are anchored to the target cell’s surface via a transmembrane domain. By using antigenic peptides and lipids that were fluorescently labeled, we found that CTLs promptly capture target cell membranes together with the antigenic peptide as well as various other surface proteins. This efficient and specific capture process requires sustained TCR signaling. Our observations indicate that this process allows efficient acquisition of the Ag by CTL, which may in turn regulate lymphocyte activation or elimination.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results and Discussion
 References
 
Upon physiological stimulation, receptors with tyrosine kinase activity (RTK)4 rapidly internalize together with their soluble ligands. The TCR clearly belongs to this family of receptors, and it too is internalized after stimulation (1). Intuitively, it seems unlikely that the TCR ligand, the peptide-MHC complex which is membrane-bound, could be efficiently transferred onto CTL. However, recently the absorption and internalization by T cells of MHC and costimulatory molecules derived from APC has been shown to occur during the recognition process (2, 3). The observation that CTL that recognized antigenic peptides subsequently became sensitive to fratricide killing (i.e., killing by T cells specific for the same Ag) (2, 3) suggested that the transfer probably involves the peptide in combination with the presenting MHC molecule. Here we examine the molecular processes involved in the capture of target cell molecules by CTL during the recognition process.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results and Discussion
 References
 
Cell lines and mice

The murine cell lines RMA and BALB/c 3T3 transfected with H-2Db (3T3-Db) were used as target cells. CTL lines specific for lymphocytic choriomeningitis virus gp33/H-2Db were derived from the P14 TCR-transgenic mouse (4) or produced by standard peptide immunization procedure of C57BL/6 (B6) perforin-deficient (PKO) mice as described previously (5). CTL lines specific for the model peptide FITC-K9L presented by H-2Db were also generated by peptide immunization.

Peptides

Synthesis of peptides has been described elsewhere (6). All peptides were HPLC-purified (>98%), and their identity was confirmed by mass spectrometry.

Functional assays

Cytotoxicity was measured in a classical 4- to 5-h (or 24-h when indicated) 51Cr release assay. For IFN-{gamma} production, 100 µl were removed after 24 h from the same wells used for cytotoxicity assays and assayed for IFN-{gamma} content by ELISA, as previously described, using R4-6A2 and biotinylated XMG1.2 (BD PharMingen, San Diego, CA) (7).

Flow cytometric analysis

Target cells were stained with the lipophylic dye PKH-26 (Sigma, St. Louis, MO) according to the manufacturer’s instruction, placed in U-bottom 96-well plates (100 µl) with the indicated concentrations of peptides (0.2 x 106cells/well in final volume of 200 µl), incubated for 1 h at 37°C, and then washed three to five times. After the last wash, cell pellets were resuspended with 100 µl of T cell suspension (0.1 x 106/ml), centrifuged for 30 s at 1000 rpm to promote conjugate formation, and then left at 37°C for 1 h (or the indicated times). Conjugates were dissociated by washing cells twice in PBS containing 0.5 mM EDTA and were then stained with anti-CD8-Tricolor. In some experiments, T cells were treated with PP2 (10 µM; Sigma) or with blocking Abs either before or after conjugate formation.


   Results and Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
References
 
To investigate how T cells acquire the antigenic peptides, we used two different fluorescently labeled antigenic peptides and measured their transfer onto specific CTL by flow cytometry. FITC-gp33 corresponded to the immunodominant epitope of the lymphocytic choriomeningitis virus (gp33, 33KAVYNFATC41) (8) to which a FITC moiety was attached on the {epsilon} amino group of Lys33, and Cys41 was replaced by Ile to avoid chemical reduction. The second peptide was the fluorescent probe FITC-K9L (FITC-KAIENAEAL) (6). Both peptides bind specifically and with a high affinity (Kd = 10–50 nM) to cells that express the H-2Db MHC class I molecule (data not shown). FITC-gp33 is recognized in cytotoxicity assays by P14 CTL specific for gp33 derived from transgenic mice expressing the P14 (V{alpha}2, V{beta}8.1) TCR (4), albeit more weakly than the original peptide (half-maximal lysis at 0.3 nM vs 1 pM, respectively; data not shown). FITC-K9L is recognized by CTL generated by standard peptide immunization.

RMA cells coated with increasing concentrations of either FITC-gp33 or FITC-K9L were thoroughly washed to remove any free peptide and were then incubated with either P14- or K9L-specific CTL. After dissociation of the conjugates, the amount of FITC-peptide acquired by the CTL was assessed by flow cytometry. As shown in Fig. 1GoA, CD8+ P14 CTL were significantly and reproducibly stained with FITC after incubation with FITC-gp33-pulsed, but not FITC-K9L-pulsed, RMA cells. Conversely, anti-K9L CTL became positively stained for FITC after incubation with FITC-K9L-pulsed, but not FITC-gp33-pulsed, RMA cells. As shown in Fig. 1GoB, P14 and K9L-specific CTL selectively acquired FITC staining in a dose-dependent manner when RMA cells were respectively coated with 10 nM-1 µM FITC-gp33 or FITC-K9L. These results demonstrate a specific and dose-dependent capture of the antigenic peptide by CTL and thus provide a molecular basis for the previously reported process of fratricide killing (2). In addition, we observed that FITC-gp33, but not FITC-K9L, induced a down-modulation of the P14 TCR that correlated closely with the acquisition of FITC-gp33 in a dose-dependent manner (data not shown).



View larger version (37K):
[in this window]
[in a new window]
  		FIGURE 1. Specific capture of target cell-derived antigenic peptides by T cells. A, RMA cells pulsed with 1 µM of FITC-gp33 (top) or FITC-K9L (bottom) were mixed with P14 CTLs (left panels) or K9L CTLs (right panels). After incubation at 37°C for 1 h, conjugates were dissociated and stained with anti-CD8-Tricolor and then analyzed by flow cytometry. The analysis was performed on gated CD8+ live T cells as identified by FSC parameter. The dark line shows green fluorescence intensity on CTLs exposed to peptide-coated RMA, as compared with noncoated ones (thin line). B, Dose-response curves of FITC-gp33 (•) or FITC-K9L ({circ}) transfer from RMA cells to P14 CTLs (left) or K9L CTLs (right). C, 3T3-Db cells biotinylated on their cell surface were pulsed (lane 2) or not (lane 1) with 1 µM gp33 and were then incubated with P14 for 30 min at 37°C. P14 CTLs were separated from 3T3-Db, lysed in N-octylglucoside, and the lysates were analyzed by Western blot analysis revealed by streptavidin-HRP and chemiluminescence. Lanes 3 and 4 correspond to small amounts of lysates from biotinylated 3T3-Db and P14, respectively.

 
Other molecules such as B7.1, B7.2, and ICAM-1 are acquired by T cells during the recognition process in parallel with MHC molecules (3, 9, 10). To evaluate the diversity of molecules acquired by CTL, the surface of living 3T3-Db cells was biotinylated. After pulsing half of them with gp33, these cells were incubated with P14 CTL. After 30 min, the CTLs were harvested, whole-cell protein extracts were prepared from them, and they were transferred to nitro-cellulose membrane after SDS-PAGE separation and probed using streptavidin-HRP. As shown in Fig. 1GoC, when p14 CTLs were mixed with gp33-pulsed 3T3-Db, the amount of detectable biotinylated molecules recovered on P14 was markedly increased (lane 2) compared with a control performed using unpulsed 3T3-Db cells (lane 1). The pattern of these biotinylated proteins differs qualitatively and quantitatively from those of 3T3-Db and even more from those of P14 (lanes 3 and 4, respectively), demonstrating that these biotinylated proteins did not come from a contamination of P14 T cells by biotinylated 3T3-Db cells or from unblocked biotinylation reagent. Therefore, CTL recognition of the peptide-MHC complex at the surface of the target cell induced the preferential transfer of a selected set of target cell-derived surface proteins onto CTL. Although it is likely that the major band detected around 45 kDa corresponds to MHC class I molecules, the precise identity of this and other proteins remains to be determined.

How might the passage onto T cells of so many different molecules from the plasma membrane of the target cell be explained? We investigated the possibility that membrane fragments could convey these proteins by analyzing the transfer to T cells of a fluorescent lipid (PKH26) initially incorporated into the target cell membranes. As shown in Fig. 2GoA, P14 CTL acquired PKH26 when incubated with RMA cells pulsed with 1 µM gp33, but not with 1 µM of the control peptide K9L or RMA cells left unpulsed. Reciprocally, significant PKH26 transfer onto K9L-specific CTL occurred only when K9L, but not gp33, was used to coat the target cells. The amount of lipid transferred depended on the dose of peptide used in both cases (Fig. 2GoB). The transfer observed specifically concerns membranes because when RMA cells were stained with CFSE, a stable internal protein dye, no transfer of fluorescence from RMA cells to P14 CTL was detected (data not shown).



View larger version (30K):
[in this window]
[in a new window]
  		FIGURE 2. Specific capture of target cell membranes by T cells. A, RMA cells were labeled with PKH26, pulsed with 1 µM of gp33 (top) or K9L (bottom), and then incubated with P14 (left) or K9L CTLs (right) for 1 h at 37°C. P14 CTLs were then analyzed by flow cytometry. RMA cells were gated out based on FSChigh and PKH26bright characteristics. The PKH26 fluorescence intensity was measured on T cells exposed to peptide-pulsed (line) as compared with unpulsed (gray fill) RMA cells. B, Dose-response curves for gp33 (•) or K9L ({circ}) used to pulse RMA cells before incubating them with P14 (left) or K9L CTLs (right).

 
When we incubated RMA cells that were both pulsed with FITC-gp33 and labeled with PKH26 with P14 CTL, we observed a parallel capture of antigenic peptide and lipid by T cells (data not shown). To a rough approximation based on levels of fluorescence intensity per cell, we estimate that after 1 h CTLs acquire 5–10% of the amount of lipid and peptide initially present on a target cell. Capture of both peptide and lipid was partially inhibited by anti-P14 TCR Abs (anti-V{alpha}2 and anti-V{beta}8.1), but not by anti-V{beta}6 or anti-TCR C{beta} control mAb (data not shown). After P14 CTLs were exposed to gp33-pulsed RMA cells, we also observed fratricide killing by fresh P14 CTLs (data not shown). These observations suggest that specific MHC-TCR interactions are directly involved in the capture process.

Interestingly, mAb 53.6.7.2 (or its Fab'), which binds to CD8{alpha}, markedly inhibited the transfer of both PKH26 (Fig. 3GoA) and FITC-gp33 (data not shown). Because this mAb stabilizes the TCR-ligand interaction but inhibits TCR-mediated signaling (11, 12), we wondered whether the capture process would require TCR signaling. To investigate this possibility, we made use of PP2, a selective inhibitor of Src family protein tyrosine kinases (PTK), which act very early in the TCR signaling cascade (13). At 10 µM, a nontoxic concentration that blocks T cell activation completely (data not shown), PP2 fully inhibited the acquisition of PKH26 by P14 CTL induced by gp33 (Fig. 3GoA). Even though we cannot exclude an effect of PP2 on endocytosis, this result, together with the Ab-blocking experiments presented above, strongly suggests a role for TCR signaling in the capture process.



View larger version (27K):
[in this window]
[in a new window]
  		FIGURE 3. Capture of target cell membranes by T cells is rapid and requires sustained TCR signaling. A, PKH26-labeled RMA cells pulsed or not with 1 µM gp33 were incubated with P14 for 1 h at 37°C (upper two panels). P14 CTLs were treated with 10 µM PP2 or 10 µg/ml 53.6.7.2 anti-CD8{alpha} mAb for 15 min at 37°C before addition to gp33-pulsed RMA cells (lower two panels). B, PKH26-labeled RMA cells pulsed with 1 µM gp33 were incubated with P14 at 37°C (•). Cell conjugates were disrupted by washing in PBS-EDTA at the indicated time points and analyzed immediately by flow cytometry. PP2 (10 µM) was added to P14 CTLs 15 min before conjugate formation ({blacksquare}) to provide a negative control. C, PP2 was added to gp33/RMA-p14 cell conjugates after incubations for the indicated times. -15, PP2 was added to P14 CTLs 15 min before conjugate formation. PKH26 capture by P14 was assessed after 1 h at 37°C. The first two bars correspond to positive and negative controls in the absence of PP2.

 
Interestingly, the transfer of RMA cell membranes to P14 CTL was already detectable after a 5-min incubation and reached its maximum as early as after 30 min, with 50% of the transfer being achieved at 12 min (Fig. 3GoB). The fact that the increase of PKH26 staining on P14 with time was progressive and followed a monomodal profile (data not shown) suggests that multiple transfers of small amounts of target cell plasma membrane occurred during CTL-target cell recognition rather than a single event involving the capture of a large piece of membrane.

As shown in Fig. 3GoC, PP2 inhibited the transfer of PKH26 to T cells even when added after conjugation, with the extent of inhibition diminishing progressively with time and indicating that a sustained TCR signaling was required to maintain the capture process. A similar time-dependence was observed with anti-CD8 mAb (data not shown). These kinetics are remarkably comparable to those for inhibition of T cell function when similar approaches are used (13, 14). Finally, these data strongly support our view that small fragments of membrane are progressively captured by CTL in a manner that can be interrupted with treatments affecting proximal events of TCR signaling.

Because PKH26 transfer required sustained TCR signaling and this signaling can be differentially affected by altered peptide ligands (APL) (15, 16), we next compared the ability of 16 APL to trigger cytotoxicity, cytokine production, and capture of PKH26. The 16 peptides all bound to H-2Db with affinities comparable to the natural peptide (i.e., around 1 nM) (data not shown). However, their effects on CTL activity were widely divergent and could be classified into six different categories according to their capacity to stimulate P14 CTL functions. As shown on Fig. 4Go, membrane capture by CTL correlates tightly with their lytic function but not with cytokine production. Considering the tight correlation between this transfer phenomenon and cytolytic activity, we compared the ability for membrane capture by gp33-specific CTLs derived from PKO mice with that of P14 CTLs. As expected, PKO CTLs were incapable of killing their targets in a 4-h assay but could do so in a 24-h assay (Fig. 5GoA). Interestingly, anti-gp33 PKO CTLs could capture target cell membranes as efficiently as P14 CTLs (Fig. 5GoB) or CTLs from B6 mice immunized with gp33 (data not shown). The 100-fold difference in the concentration of peptide required for the half-maximal capture to be reached in PKO vs P14 CTLs relates to the avidity of both CTL lines for the Ag (Fig. 5GoA). Finally, the kinetics of membrane capture was also the same when PKO or P14 CTLs were used (data not shown). Therefore, these observations rule out that this capture process requires the involvement of perforin’s cytolytic activity and indicate that the capture process is not a consequence of perforin-mediated damages caused to target cells. The possibility that CTLs scavenge membrane fragments nonspecifically was ruled out by that fact that K9L-specific CTLs did not capture any PKH26 when coincubated with P14 CTLs in the presence of PKH26-labeled RMA cells pulsed with gp33 (data not shown). The tight correlation between short-term (perforin-dependent) cytotoxicity and membrane capture indicate that either these two processes are independent but have similar requirements or that they are intimately linked. In light of our data, membrane capture is independent of perforin release and could correspond to an initial "love bite" preceding CTL’s kiss of death. Further studies are required to explore the nature of the correlative link we observed between these two events.



View larger version (43K):
[in this window]
[in a new window]
  		FIGURE 4. Induction of target cell membrane capture by altered peptide ligands. RMA cells pulsed with the indicated concentrations of peptides were tested for their ability to activate P14 cytotoxicity in a 51Cr release assay (upper row), target cell membrane capture by flow cytometry (middle row), and IFN-{gamma} production by ELISA. The names of the APL used to obtain the data shown here are indicated on the top row, and those of additional APL with similar behavior are indicated at the bottom of each column.

 


View larger version (18K):
[in this window]
[in a new window]
  		FIGURE 5. Target cell membrane capture by perforin-deficient CTL cytotoxicity. A, RMA cells pulsed with the indicated concentrations of gp33 were challenged with P14 CTLs (•) or gp33-specific CTLs generated in PKO B6 mice ({circ}) for 1 h at 37°C in a 4-h (left panel) or 24-h (right panel) 51Cr release assay. In control samples using K9L-pulsed RMA cells, no killing was observed after short or long incubation (data not shown). B, Capture of target cell membranes was analyzed by flow cytometry after incubating the two CTL populations for 60 min with PKH26-labeled gp33-pulsed RMA cells.

 
One point to consider is the role(s) that this capture phenomenon might play in regulating CTL activity. By providing prolonged engagement of the TCR, membrane fragments captured from Ag-bearing target cells could in the first place favor T cell activation. However, whether soluble or membrane-bound ligands of RTK could participate in signaling once inside the cell is still a matter of debate (17, 18). In turn, in the case of important antigenic load, those activated CTL will inherit enough antigenic material to become sensitized to killing by other CTLs carrying TCRs of the same specificity as their own. This fratricide killing was proposed previously to explain the phenomenon of lymphocyte "exhaustion" (2, 3, 19). Our data not only support this notion, but also provide a mechanistic explanation for this phenomenon.


   Acknowledgments
 
We thank S. Julien for blot analysis, J. P. M. van Meerwijk, P. Romagnoli, C. Featherstone, and S. Valitutti for helpful discussion and critical reading of the manuscript, and J. C. Guery for PKO mice and mAb to IFN-{gamma}.


   Footnotes
 
1 This work was supported by grants from Centre National de la Recherche Scientifique (to J.E.G. and E.J.), Institut National de la Santé et de la Recherche Médicale (to E.J.), Fondation pour la Recherche Médicale (to E.J.), and Association pour la Recherche sur le Cancer (contract number 5485 to J.E.G). Back

2 Address correspondence and reprint requests to Dr. Denis Hudrisier, Institut National de la Santé et de la Recherche Médicale, Centre Hospitalier Universitaire Purpan, BP3028, 31024 Toulouse Cedex 03, France. Back

3 J.E.G. and E.J. contributed equally to this work. Back

4 Abbreviations used in this paper: RTK, receptors with tyrosine kinase activity; PTK, protein tyrosine kinases; B6, C57BL/6; APL, altered peptide ligands; PKO, perforin-deficient; FSC, forward light scatter. Back

Received for publication December 8, 2000. Accepted for publication January 18, 2001.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results and Discussion
 References
 

  1. Valitutti, S., S. Muller, M. Cella, E. Padovan, A. Lanzavecchia. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375:148.[Medline]
  2. Huang, J. F., Y. Yang, H. Sepulveda, W. Shi, I. Hwang, P. A. Peterson, M. R. Jackson, J. Sprent, Z. Cai. 1999. TCR-mediated internalization of peptide-MHC complexes acquired by T cells. Science 286:952.[Abstract/Free Full Text]
  3. Hwang, I., J. F. Huang, H. Kishimoto, A. Brunmark, P. A. Peterson, M. R. Jackson, C. D. Surh, Z. Cai, J. Sprent. 2000. T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen-presenting cells. J. Exp. Med. 191:1137.[Abstract/Free Full Text]
  4. Pircher, H., E. E. Michalopoulos, A. Iwamoto, P. S. Ohashi, J. Baenziger, H. Hengartner, R. M. Zinkernagel, T. W. Mak. 1987. Molecular analysis of the antigen receptor of virus-specific cytotoxic T cells and identification of a new V{alpha} family. Eur. J. Immunol. 17:1843.[Medline]
  5. Hudrisier, D., J. Riond, H. Mazarguil, M. B. A. Oldstone, J. E. Gairin. 1999. Genetically encoded and post-translationally modified forms of a major histocompatibility complex class I-restricted antigen bearing a glycosylation motif are independently processed and co-presented to cytotoxic T lymphocytes. J. Biol. Chem. 274:36274.[Abstract/Free Full Text]
  6. Hudrisier, D., H. Mazarguil, M. B. A. Oldstone, J. E. Gairin. 1995. Relative implication of peptide residues in binding to major histocompatibility complex class I H-2Db: application to the design of high-affinity, allele-specific peptides. Mol. Immunol. 32:895.[Medline]
  7. Hudrisier, D., B. Kessler, S. Valitutti, C. Horvath, J.-C. Cerottini, I. F. Luescher. 1998. The efficiency of antigen recognition by CD8+ CTL clones is determined by the frequency of serial TCR engagement. J. Immunol. 161:553.[Abstract/Free Full Text]
  8. Oldstone, M. B., J. L. Whitton, H. Lewicki, A. Tishon. 1988. Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes. J. Exp. Med. 168:559.[Abstract/Free Full Text]
  9. Patel, D. M., P. Y. Arnold, G. A. White, J. P. Nardella, M. D. Mannie. 1999. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition. J. Immunol. 163:5201.[Abstract/Free Full Text]
  10. Arnold, P. Y., M. D. Mannie. 1999. Vesicles bearing MHC class II molecules mediate transfer of antigen from antigen-presenting cells to CD4+ T cells. Eur. J. Immunol. 29:1363.[Medline]
  11. Luescher, I. F., E. Vivier, A. Layer, J. Mahiou, F. Godeau, B. Malissen, P. Romero. 1995. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 373:353.[Medline]
  12. Daniels, M. A., S. C. Jameson. 2000. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J. Exp. Med. 191:335.[Abstract/Free Full Text]
  13. Muller, S., S. Demotz, C. Bulliard, S. Valitutti. 1999. Kinetics and extent of protein tyrosine kinase activation in individual T cells upon antigenic stimulation. Immunology 97:287.[Medline]
  14. Valitutti, S., M. Dessing, K. Aktories, H. Gallati, A. Lanzavecchia. 1995. Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. J. Exp. Med. 181:577.[Abstract/Free Full Text]
  15. Germain, R. N., I. Stefanova. 1999. The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation. Annu. Rev. Immunol. 17:467.[Medline]
  16. Hudrisier, D., I. F. Luescher. 2000. Antigen recognition by CD8+ CTLs. M. V. Sitkouski, and P. A. Heukazt, eds. Cytotoxic Cells: Basic Mechanisms and Medical Applications 25. Lippincott Williams & Wilkins, Philadelphia.
  17. Cagan, R. L., H. Kramer, A. C. Hart, S. L. Zipursky. 1992. The bride of sevenless and sevenless interaction: internalization of a transmembrane ligand. Cell 69:393.[Medline]
  18. Kramer, H.. 1993. Patrilocal cell-cell interactions: sevenless captures its bride. Trends Cell Biol. 3:103.[Medline]
  19. Hanon, E., J. Stinchcombe, M. Saito, B. Asquith, G. Taylor, Y. Tanaka, J. Weber, G. Griffiths, C. Bangham. 2000. Fratricide among CD8+ T lymphocytes naturally infected with human T cell lymphotropic virus type I. Immunity 16:657.



This article has been cited by other articles:


Home page
 J. Immunol.Home page
D. Hudrisier, B. Clemenceau, S. Balor, S. Daubeuf, E. Magdeleine, M. Daeron, P. Bruhns, and H. Vie
Ligand Binding but Undetected Functional Response of FcR after Their Capture by T Cells via Trogocytosis
J. Immunol., November 15, 2009; 183(10): 6102 - 6113.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Marcenaro, C. Cantoni, S. Pesce, C. Prato, D. Pende, S. Agaugue, L. Moretta, and A. Moretta
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction
Blood, November 5, 2009; 114(19): 4108 - 4116.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. V. Beum, D. A. Mack, A. W. Pawluczkowycz, M. A. Lindorfer, and R. P. Taylor
Binding of Rituximab, Trastuzumab, Cetuximab, or mAb T101 to Cancer Cells Promotes Trogocytosis Mediated by THP-1 Cells and Monocytes
J. Immunol., December 1, 2008; 181(11): 8120 - 8132.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
M. Poupot, J.-J. Fournie, and R. Poupot
Trogocytosis and killing of IL-4-polarized monocytes by autologous NK cells
J. Leukoc. Biol., November 1, 2008; 84(5): 1298 - 1305.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. S. Ford McIntyre, K. J. Young, J. Gao, B. Joe, and L. Zhang
Cutting Edge: In Vivo Trogocytosis as a Mechanism of Double Negative Regulatory T Cell-Mediated Antigen-Specific Suppression
J. Immunol., August 15, 2008; 181(4): 2271 - 2275.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Aucher, E. Magdeleine, E. Joly, and D. Hudrisier
Capture of plasma membrane fragments from target cells by trogocytosis requires signaling in T cells but not in B cells
Blood, June 15, 2008; 111(12): 5621 - 5628.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Machlenkin, R. Uzana, S. Frankenburg, G. Eisenberg, L. Eisenbach, J. Pitcovski, R. Gorodetsky, A. Nissan, T. Peretz, and M. Lotem
Capture of Tumor Cell Membranes by Trogocytosis Facilitates Detection and Isolation of Tumor-Specific Functional CTLs
Cancer Res., March 15, 2008; 68(6): 2006 - 2013.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
I. A. Cockburn, S. Chakravarty, M. G. Overstreet, A. Garcia-Sastre, and F. Zavala
Memory CD8+ T Cell Responses Expand When Antigen Presentation Overcomes T Cell Self-Regulation
J. Immunol., January 1, 2008; 180(1): 64 - 71.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. H. Cox, A. J. McMichael, G. R. Screaton, and X.-N. Xu
CTLs Target Th Cells That Acquire Bystander MHC Class I-Peptide Complex from APCs
J. Immunol., July 15, 2007; 179(2): 830 - 836.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
P. Roda-Navarro and H. T. Reyburn
Intercellular protein transfer at the NK cell immune synapse: mechanisms and physiological significance
FASEB J, June 1, 2007; 21(8): 1636 - 1646.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Adamopoulou, J. Diekmann, E. Tolosa, G. Kuntz, H. Einsele, H.-G. Rammensee, and M. S. Topp
Human CD4+ T Cells Displaying Viral Epitopes Elicit a Functional Virus-Specific Memory CD8+ T Cell Response
J. Immunol., May 1, 2007; 178(9): 5465 - 5472.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Hudrisier, A. Aucher, A.-L. Puaux, C. Bordier, and E. Joly
Capture of Target Cell Membrane Components via Trogocytosis Is Triggered by a Selected Set of Surface Molecules on T or B Cells
J. Immunol., March 15, 2007; 178(6): 3637 - 3647.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Z. Garcia, E. Pradelli, S. Celli, H. Beuneu, A. Simon, and P. Bousso
Competition for antigen determines the stability of T cell-dendritic cell interactions during clonal expansion
PNAS, March 13, 2007; 104(11): 4553 - 4558.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. LeMaoult, J. Caumartin, M. Daouya, B. Favier, S. L. Rond, A. Gonzalez, and E. D. Carosella
Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells
Blood, March 1, 2007; 109(5): 2040 - 2048.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
K.-J. Li, M.-C. Lu, S.-C. Hsieh, C.-H. Wu, H.-S. Yu, C.-Y. Tsai, and C.-L. Yu
Release of surface-expressed lactoferrin from polymorphonuclear neutrophils after contact with CD4+T cells and its modulation on Th1/Th2 cytokine production
J. Leukoc. Biol., August 1, 2006; 80(2): 350 - 358.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Bourbie-Vaudaine, N. Blanchard, C. Hivroz, and P.-H. Romeo
Dendritic Cells Can Turn CD4+ T Lymphocytes into Vascular Endothelial Growth Factor-Carrying Cells by Intercellular Neuropilin-1 Transfer
J. Immunol., August 1, 2006; 177(3): 1460 - 1469.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Mayerova, L. Wang, L. S. Bursch, and K. A. Hogquist
Conditioning of langerhans cells induced by a primary CD8 T cell response to self-antigen in vivo.
J. Immunol., April 15, 2006; 176(8): 4658 - 4665.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Romagnoli, D. Hudrisier, and J. P. M. van Meerwijk
Molecular Signature of Recent Thymic Selection Events on Effector and Regulatory CD4+ T Lymphocytes
J. Immunol., November 1, 2005; 175(9): 5751 - 5758.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Poupot, F. Pont, and J.-J. Fournie
Profiling Blood Lymphocyte Interactions with Cancer Cells Uncovers the Innate Reactivity of Human {gamma}{delta} T Cells to Anaplastic Large Cell Lymphoma
J. Immunol., February 1, 2005; 174(3): 1717 - 1722.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. A. Wetzel, T. W. McKeithan, and D. C. Parker
Peptide-Specific Intercellular Transfer of MHC Class II to CD4+ T Cells Directly from the Immunological Synapse upon Cellular Dissociation
J. Immunol., January 1, 2005; 174(1): 80 - 89.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. Vanherberghen, K. Andersson, L. M. Carlin, E. N. M. Nolte-`t Hoen, G. S. Williams, P. Hoglund, and D. M. Davis
Human and murine inhibitory natural killer cell receptors transfer from natural killer cells to target cells
PNAS, November 30, 2004; 101(48): 16873 - 16878.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. F. Angelini, G. Borsellino, M. Poupot, A. Diamantini, R. Poupot, G. Bernardi, F. Poccia, J.-J. Fournie, and L. Battistini
Fc{gamma}RIII discriminates between 2 subsets of V{gamma}9V{delta}2 effector cells with different responses and activation pathways
Blood, September 15, 2004; 104(6): 1801 - 1807.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Maranon, J.-F. Desoutter, G. Hoeffel, W. Cohen, D. Hanau, and A. Hosmalin
Dendritic cells cross-present HIV antigens from live as well as apoptotic infected CD4+ T lymphocytes
PNAS, April 20, 2004; 101(16): 6092 - 6097.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. J. Mekala and T. L. Geiger
Functional Segregation of the TCR and Antigen-MHC Complexes on the Surface of CTL
J. Immunol., October 15, 2003; 171(8): 4089 - 4095.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Poupot and J.-J. Fournie
Spontaneous Membrane Transfer Through Homotypic Synapses Between Lymphoma Cells
J. Immunol., September 1, 2003; 171(5): 2517 - 2523.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Tabiasco, A. Vercellone, F. Meggetto, D. Hudrisier, P. Brousset, and J.-J. Fournie
Acquisition of Viral Receptor by NK Cells Through Immunological Synapse
J. Immunol., June 15, 2003; 170(12): 5993 - 5998.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Y. S. Tsang, J. G. Chai, and R. Lechler
Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion?
Blood, April 1, 2003; 101(7): 2704 - 2710.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Espinosa, J. Tabiasco, D. Hudrisier, and J.-J. Fournie
Synaptic Transfer by Human {gamma}{delta} T Cells Stimulated with Soluble or Cellular Antigens
J. Immunol., June 15, 2002; 168(12): 6336 - 6343.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
D. HUDRISIER and P. BONGRAND
Intercellular transfer of antigen-presenting cell determinants onto T cells: molecular mechanisms and biological significance
FASEB J, April 1, 2002; 16(6): 477 - 486.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
L. M. Carlin, K. Eleme, F. E. McCann, and D. M. Davis
Intercellular Transfer and Supramolecular Organization of Human Leukocyte Antigen C at Inhibitory Natural Killer Cell Immune Synapses
J. Exp. Med., November 19, 2001; 194(10): 1507 - 1517.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
J. Zimmer, V. Ioannidis, and W. Held
H-2D Ligand Expression by Ly49A+ Natural Killer (NK) Cells Precludes Ligand Uptake from Environmental Cells: Implications for NK Cell Function
J. Exp. Med., November 19, 2001; 194(10): 1531 - 1539.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hudrisier, D.
Right arrow Articles by Joly, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hudrisier, D.
Right arrow Articles by Joly, E.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS